Click here to read the Cover Story, “Digital future of ophthalmology is now.”As ophthalmology practices continue to embrace digital transformation, one of the greatest challenges is not the technology itself — it is managing expectations.That might sou…
Click here to read the Cover Story, “Digital future of ophthalmology is now.”As ophthalmology practices continue to embrace digital transformation, one of the greatest challenges is not the technology itself — it is managing expectations.That might sou…
ORLANDO — In this video, David A. Eichenbaum, MD, FASRS, discusses late-stage wet age-related macular degeneration assets presented at the American Academy of Ophthalmology meeting.Eichenbaum noted that tyrosine kinase inhibitors and gene therapy progr…
Getting new employees ready to do their jobs can be a big undertaking for an eye care practice, no matter its size.Training technicians, scribes and receptionists takes time and energy away from current staff members who already have a lot on their pla…
WHIPPANY, N.J.–(BUSINESS WIRE)–U.S. FDA Approves HYRNUO® (sevabertinib) for Previously Treated Patients with HER2-Mutated Locally Advanced or Metastatic Non-Squamous NSCLC
Early recognition of Sjögren syndrome is essential because timely diagnosis and coordinated follow-up reduce systemic complications, including the risk for lymphoma. Medscape News UK